TITLE

CENTRAL NERVOUS SYSTEM

PUB. DATE
January 2010
SOURCE
Monthly Prescribing Reference;Jan2010, Vol. 26 Issue 1, p61
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article offers information on the labeling of several drugs for treatment of central nervous system diseases including Lunesta from Sepracor Pharmaceuticals, Restoril from Mallinckrodt Inc. and Ativan from Biovail Pharmaceuticals Inc. Lunesta is indicated for insomnia and is not recommended for children who are less than 18 years old. Adults should take 7.5-30 milligrams of Restoril during bedtime. Ativan has several adverse reactions including dizziness and weakness.
ACCESSION #
52045869

 

Related Articles

  • CENTRAL NERVOUS SYSTEM.  // Physician Assistants' Prescribing Reference;Winter2010, Vol. 17 Issue 4, p57 

    The article offers information on several drugs that are used to treat and manage central nervous system disorders. The drugs include Ambien CR from Sanofi Aventis Ltd., Lunesta from Sepracor Inc., and Restoril from Mallinckrodt Inc. Moreover, the article provides the prescribing notes,...

  • CENTRAL NERVOUS SYSTEM.  // Physician Assistants' Prescribing Reference;Summer2010, Vol. 17 Issue 2, p55 

    The article offers information on various drugs for central nervous system diseases. It says that Lunesta is a pyrrolopyrazine hypnotic from Sepracor Pharmaceuticals which is used to treat insomnia and is applicable for adults who are at least 18 years old. The ativan is a benzodiazepine from...

  • SECTION 3: CENTRAL NERVOUS SYSTEM.  // Monthly Prescribing Reference;Apr2010, Vol. 26 Issue 4, p63 

    The article offers information on the medications and drugs used to treat central nervous system (CNS) diseases such as insomnia and anxiety. It states that Lunesta from Speracor is used for insomia but it can cause depression and behavioal changes. Meanwhile, CNS depression, dizziness, and...

  • CENTRAL NERVOUS SYSTEM.  // Monthly Prescribing Reference;Apr2011, Vol. 27 Issue 4, p67 

    The article presents the drugs that are used in treating central nervous system diseases. The drugs include Sanofi-Aventis SA' s Ambien CR for insomia, Mallinckrodt Inc.'s Anafranil for anxiety and obsessive-compulsive disorder (OCD), and GlaxoSmithKline's Chlorpromazine for psychosis. It...

  • SECTION 3: CENTRAL NERVOUS SYSTEM.  // MPR - Pharmacist's Edition;Winter2011/2012, Vol. 5 Issue 4, p54 

    The article offers brief information on several drugs for diseases in central nervous system along with their indications and adverse effects which include Dalmane from Valeant Pahrmaceuticals Inc., Lunesta from Sunovion Pharmaceuticals Inc., and Restoril from Mallinckrodt Inc.

  • CENTRAL NERVOUS SYSTEM.  // Monthly Prescribing Reference;Sep2011, Vol. 27 Issue 9, p69 

    The article offers information on several drugs for the treatment of diseases in central nervous system including insomnia, anxiety, and psychosis. It says that Halcion from Pfizer Inc. is not recommended for children below 18 years old. It states the adverse reactions of Anafranil from...

  • SECTION 3: CENTRAL NERVOUS SYSTEM.  // MPR - Pharmacist's Edition;Spring2010, Vol. 4 Issue 1, p52 

    The article provides information on several drugs for central nervous system diseases including Zolpidem tartrate (Ambien CR), Flurazepam hydrochloride (Dalmane) and Quazepam (Doral). It states that Ambien CR is indicated for insomnia and its effect is delayed if taken with meal. It cites that...

  • Bupivacaine.  // Reactions Weekly;9/15/2007, Issue 1169, p10 

    The article describes the case of an 18-year old woman who developed central nervous system (CNS) toxicity after inadvertent intravenous (IV) administration of bupivacaine and was treated successfully with soya oil emulsion. She had borderline hypertension, mild proteinuria and an unsatisfactory...

  • Stroke after Initiating IV Penicillin for Neurosyphilis: A Possible Jarisch-Herxheimer Reaction. Punia, Vineet; Rayi, Appaji; Sivaraju, Adithya // Case Reports in Neurological Medicine;2014, p1 

    Introduction. Syphilis incidence has increased in the US in the last decade. Jarisch-Herxheimer reaction (JHR) is a well-documented adverse effect of penicillin treatment in syphilis. Stroke has not been reported as part of its phenomenology. Case Report. A 57-year-old man presented with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics